Zhaoke Ophthalmology-B: Beimei Prostaglandin Eye Drops (Jingbeiqing®) Approved by the National Medical Products Administration for Marketing
I'm PortAI, I can summarize articles.
Zhaoke Ophthalmology-B announced that its research and development of the anti-glaucoma drug Bimatoprost eye drops (Crystal Clear®) has been approved by the National Medical Products Administration for marketing. This is the first single-dose Bimatoprost eye drops in China without preservatives, aimed at reducing intraocular pressure in patients with open-angle glaucoma and ocular hypertension, improving patient comfort, and enhancing medication compliance
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments